[Possibilities of treatment of external pancreatic fistula].

Abstract

Evaluation of the efficacy of sekretolitičeskoj therapy with synthetic analogue of somatostatin, a short-acting oktreotid (group 1) and extended oktreotid-depo (group 2) in 24 patients with external pancreatic fistulas after destructive pancreatitis. Results of clinical studies have shown that against the backdrop of an analogue of somatostatin-depo true healing and purulent-necrotic pancreatic external fistula occurs in less time: average 19 ± 1.8, and 16.2 ± 1.2 day observations, respectively.

• Authors: D V Cherdantsev, O V Pervova, V Iu Diatlov, D Sh Kurbanov
• Journal: Khirurgiia (Khirurgiia (Mosk)) Issue 8 Pg. 62-6 ( 2014) ISSN: 0023-1207 [Print] Russia (Federation)
• PMID: 25327679 (Publication Type: Journal Article)

Chemical References

• Anti-Bacterial Agents
• Dosage Forms
• Gastrointestinal Agents
• Amylases
• Octreotide

Topics

• Adult
• Amylases (metabolism)
• Anti-Bacterial Agents (administration & dosage)
• Comparative Effectiveness Research
• Cutaneous Fistula (drug therapy, etiology, metabolism)
• Dosage Forms
• Drug Therapy, Combination
• Female
• Gastrointestinal Agents (administration & dosage)
• Humans
• Injections, Intramuscular
• Male
• Middle Aged
• Octreotide (administration & dosage)
• Pancreas, Exocrine (drug effects, metabolism)
• Pancreatic Fistula (drug therapy, etiology, metabolism)
• Pancreatitis (complications)
• Treatment Outcome
• Wound Healing (drug effects)